Drug–Drug Interaction Network Analysis
Overview

This repository contains a graph-based analysis pipeline for exploring drug–drug interactions (DDIs) using Python and the NetworkX ecosystem. The notebook focuses on transforming structured interaction data into a network representation and investigating the structural characteristics of the resulting graph through statistical analysis, centrality measures, community detection, hub analysis, and subgraph exploration.

The project demonstrates how network science techniques can be applied to biomedical interaction data in order to:

Understand interaction topology
Identify highly connected drugs (hubs)
Detect bridge or bottleneck nodes
Explore local clustering behavior
Investigate interaction communities
Analyze connectivity patterns among major interaction centers

The workflow combines data processing, graph theory, exploratory analysis, and visualization within a single Jupyter Notebook.

Dataset Structure

The analysis assumes a dataset containing at least the following columns:

Column	Description
Drug 1	Source drug
Drug 2	Target drug
Interaction Description	Textual description of the interaction

Each row represents a drug–drug interaction relationship that is converted into an edge within the graph.

Graph Construction

The notebook constructs an undirected interaction graph using NetworkX:

Drugs are represented as nodes
Interactions are represented as edges
Interaction descriptions are stored as edge attributes

The graph is generated directly from the tabular dataset using nx.from_pandas_edgelist().

Analytical Workflow
1. Initial Statistical Exploration

The notebook begins with general graph statistics to provide a high-level overview of the interaction network:

Number of nodes
Number of edges
Degree distribution statistics
Average degree
Highest and lowest degree nodes

These metrics provide a structural summary of the interaction landscape.

2. Connectivity Analysis

The notebook investigates graph connectivity using connected component analysis.

This section identifies:

Isolated subnetworks
Largest connected component (LCC)
Overall network cohesion

Connectivity analysis helps determine whether the interaction network is dominated by a single large interaction region or fragmented into multiple groups.

3. Centrality Analysis

Several classical centrality measures are computed to identify structurally important drugs.

Degree Centrality

Measures the number of direct interactions associated with each drug.

Betweenness Centrality

Identifies drugs that act as bridges between different regions of the network.

Closeness Centrality

Evaluates how efficiently a drug can reach the rest of the network.

These measures help distinguish:

Highly interactive drugs
Structurally influential nodes
Potential bottleneck drugs
4. Density and Clustering

The notebook evaluates:

Graph density
Local clustering coefficients
Average clustering behavior

This provides insight into:

Overall interaction compactness
Formation of tightly connected neighborhoods
Local interaction organization
5. Triangle and Motif Analysis

Triangle counting is used as a lightweight motif analysis approach.

Triangles can indicate:

Mutually interacting drug groups
Dense local structures
Shared pharmacological relationships

The notebook computes both node-level and total triangle counts.

6. Hub Investigation

The analysis includes a dedicated study of highly connected drugs.

Multiple hub identification strategies are implemented:

Top-k hub selection
Percentile-based thresholding
Statistical Z-score thresholding

The notebook then constructs a subgraph consisting of the top 50 hub drugs to examine:

Internal connectivity
Subgraph density
Interaction concentration among dominant nodes

This section provides a focused view of the network core.

7. Adverse Effect Interaction Filtering

A subset of interactions related to increased adverse effects is extracted using text-based filtering of interaction descriptions.

This exploratory section demonstrates how semantic filtering can be combined with graph analysis to isolate specific categories of interactions.

The filtered subset is subsequently visualized as a dedicated interaction network.

8. Bottleneck / Bridge Detection

The notebook performs a dedicated bottleneck analysis using betweenness centrality.

Key features of this section include:

Analysis on the Largest Connected Component (LCC)
Exact betweenness computation for smaller graphs
Approximate betweenness computation for scalability on larger networks
Ranking of structurally critical bridge nodes

The workflow includes configurable thresholds for balancing computational efficiency and analytical precision.

9. Community Detection

Two community detection strategies are implemented.

Greedy Modularity Optimization

Used to identify densely connected regions in the graph based on modularity maximization.

Louvain Community Detection

A scalable modularity-based method used for partitioning large graphs into interaction communities.

The notebook:

Assigns community labels to drugs
Computes community size distributions
Visualizes the largest detected communities

This section helps reveal latent organizational structure within the interaction network.

Visualization

The notebook includes multiple graph visualizations using Matplotlib and NetworkX layouts.

Visualization tasks include:

Full network rendering
Hub-centered subgraphs
Community visualization
Adverse effect interaction networks

Spring-layout positioning is used extensively for spatial organization of graph structures.

Technologies Used
Core Libraries
Python
Pandas
NumPy
Matplotlib
NetworkX
Community Detection
python-louvain
Project Structure
.
├── drug-drug-interaction.ipynb
└── README.md
Running the Notebook
1. Clone the Repository
git clone <repository-url>
cd <repository-folder>
2. Install Dependencies
pip install pandas numpy matplotlib networkx python-louvain
3. Launch Jupyter Notebook
jupyter notebook

Then open:

drug-drug-interaction.ipynb
Notes
The notebook is designed primarily for exploratory graph analysis.
Some analytical sections intentionally prioritize interpretability and structural insight over domain-specific pharmacological modeling.
The adverse effect extraction section uses lightweight text filtering and is included as an exploratory example rather than a clinical inference pipeline.
Community detection and centrality calculations may require additional computation time for very large interaction graphs.
Potential Extensions

Future improvements could include:

Weighted interaction graphs
Directed interaction modeling
Temporal interaction analysis
NLP-based interaction classification
Graph embeddings
Link prediction
Graph neural network integration
Interactive graph visualization frameworks
Contact

For questions or collaboration:

Shayan Rokhva
shayanrokhva1999@gmail.com
